...

Cannabidiol and Cannabis Concentrate Users: A Randomized, Placebo Controlled Study

The purpose of this research study is to learn more about how cannabidiol (CBD) may affect cannabis use, effects, and craving.


Why this Research Matters

Study participation will include 4 visits over about 5 weeks, with an on-campus screening visit and three home-based visits in our mobile pharmacology lab, a specially equipped van. Participation will involve taking cannabidiol (CBD) or a placebo.


Who can Participate

Adult

Inclusion Criteria: - Age 25-60 - Regular user of cannabis concentrates - Not currently seeking to cut down or stop cannabis use Not everyone will qualify to be in the study. Other inclusion and exclusion criteria will be evaluated by the study team.


Study ID

Protocol Number: 23-0953
More information available at ClinicalTrials.gov: NCT06575751

Meet the Team

Image of Principal Investigator

Joseph Schacht, PhD

Principal Investigator